Jessica Hopfield's Insider Trades & SAST Disclosures
Jessica Hopfield's most recent trade in Insulet Corporation was a trade of 7,628 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 11, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jessica Hopfield.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insulet Corporation | Jessica Hopfield | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 7,628 | 0 | - | - | Stock Option (Right to Buy) | |
| Insulet Corporation | Jessica Hopfield | Director | Sale of securities on an exchange or to another person at price $ 225.26 per share. | 11 Sep 2024 | 7,628 | 26,917 (0%) | 0% | 225.3 | 1,718,283 | Common Stock |
| Insulet Corporation | Jessica Hopfield | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.87 per share. | 11 Sep 2024 | 7,628 | 34,545 (0%) | 0% | 29.9 | 227,848 | Common Stock |
| Editas Medicine Inc | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Maravai LifeSciences Holdi... | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 10.78 per share. | 23 May 2024 | 20,645 | 110,768 | - | 10.8 | 222,553 | Class A Common Stock |
| Insulet Corporation | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 1,380 | 26,917 (0%) | 0% | 0 | Common Stock | |
| Editas Medicine Inc | Jessica Hopfield | Director | Purchase of securities on an exchange or from another person at price $ 5.64 per share. | 13 May 2024 | 45,000 | 67,700 (0%) | 0% | 5.6 | 253,868 | Common Stock |
| Maravai LifeSciences Holdi... | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 24,000 | 90,123 | - | 0 | Class A Common Stock | |
| Editas Medicine Inc | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| PhenomeX Inc | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 70,000 | 179,237 | - | 0 | Common Stock | |
| Insulet Corporation | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 843 | 25,537 (0%) | 0% | 0 | Common Stock | |
| Editas Medicine Inc | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| PhenomeX Inc | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 32,258 | 32,258 | - | - | Stock Option (Right to Buy) | |
| PhenomeX Inc | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 19,565 | 109,237 | - | 0 | Common Stock | |
| Insulet Corporation | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 1,009 | 24,694 (0%) | 0% | 0 | Common Stock | |
| Maravai LifeSciences Holdi... | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 4,271 | 66,123 | - | 0 | Class A Common Stock | |
| Editas Medicine Inc | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 11,538 | 11,538 | - | - | Stock Option (right to buy) | |
| Insulet Corporation | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 808 | 23,685 (0%) | 0% | 0 | Common Stock | |
| Editas Medicine Inc | Jessica Hopfield | Director | Purchase of securities on an exchange or from another person at price $ 45.51 per share. | 03 Mar 2021 | 5,800 | 22,700 (0%) | 0% | 45.5 | 263,970 | Common Stock |
| Maravai LifeSciences Holdi... | Jessica Hopfield | Director | Purchase of securities on an exchange or from another person at price $ 27.00 per share. | 24 Nov 2020 | 50,000 | 61,852 | - | 27 | 1,350,000 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2020 | 11,852 | 11,852 | - | 0 | Class A Common Stock | |
| Editas Medicine Inc | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 11,538 | 11,538 | - | - | Stock Option (right to buy) | |
| Insulet Corporation | Jessica Hopfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2020 | 1,029 | 22,877 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges